Drilldown: Medicines
Appearance
Medicines > classes
:
Antidepressant
or
Stimulant
or
[[:Category:NSAIDs|Non-steroidal anti-inflammatory drug (NSAID)]] 
:
Antidepressant
or
Stimulant
or
[[:Category:NSAIDs|Non-steroidal anti-inflammatory drug (NSAID)]] 
Use the filters below to narrow your results.
generic:
None (43) ·
Anafranil (1) ·
Aurorix (1) ·
Benzedrex (1) ·
Cymbalta, Drizalma Sprinkle, Irenka, Yentreve (1) ·
Edronax (1) ·
Fetzima (1) ·
Lodine (US brand discontinued); generic (1) ·
Ludiomil (1) ·
Marplan (1) ·
Nardil (1) ·
Norpramin (1) ·
Parnate (1) ·
Relafen (1) ·
Savella (1) ·
Serzone (1) ·
Stablon (1) ·
Surmontil (1) ·
Tofranil (1) ·
Valdoxan (1) ·
Vivactil (1) ·
Zoloft (1)
mechanism:
Monoamine releasing agent (8) ·
Dopamine/norepinephrine reuptake inhibitor (5) ·
Selective norepinephrine reuptake inhibitor (4) ·
Irreversible non-selective MAO inhibitor (3) ·
Serotonin and norepinephrine reuptake inhibitor (3) ·
Cathinone analogue; monoamine reuptake inhibitor (2) ·
Dopamine and norepinephrine reuptake inhibitor (2) ·
Norepinephrine–dopamine reuptake inhibitor (2) ·
Serotonin–norepinephrine reuptake inhibitor (2)
None (61) ·
Depression, anxiety, neuropathic pain, fibromyalgia, chronic musculoskeletal pain (1) ·
'"`UNIQ--vote-000011F6-QINU`"', '"`UNIQ--vote-000011F7-QINU`"', '"`UNIQ--vote-000011F8-QINU`"' (1) ·
'"`UNIQ--vote-0000126B-QINU`"', '"`UNIQ--vote-0000126C-QINU`"', '"`UNIQ--vote-0000126D-QINU`"' (1)
None (60) ·
Absolute bioavailability not precisely characterized; food modestly increases exposure (1) ·
~100% (oral; absorption complete)'"`UNIQ--ref-0000126F-QINU`"' (1) ·
~38% (oral; non-acidic prodrug improves GI tolerability over many other NSAIDs)'"`UNIQ--ref-000011FA-QINU`"' (1) ·
~50% (highly variable) (1)
None (60) ·
Avoid after 20 weeks (NSAID-class FDA 2020 advisory on fetal renal injury and oligohydramnios with second/third-trimester use).<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Avoid after 20 weeks (NSAID-class FDA 2020 advisory).<sup class="pcp-cn" title="This claim needs a citation.">[[[Pharmacopedia:Citation needed|citation needed]]]</sup> (1) ·
Category C (1) ·
Category C'"`UNIQ--ref-0000008F-QINU`"' (1)
None (60) ·
Rx-only (1) ·
Rx-only in US (1) ·
[[USLegal:Prescription only|Rx-only]] in US. Carries the NSAID-class '''Boxed Warning''' for cardiovascular thrombotic events and serious GI bleeding'"`UNIQ--ref-000011FB-QINU`"' (1) ·
[[USLegal:Prescription only|Rx-only]] in US. NSAID-class '''Boxed Warning''' for CV thrombotic events and GI bleeding'"`UNIQ--ref-00001270-QINU`"' (1)
Showing below up to 64 results in range #1 to #64.
2
3
4
A
B
C
D
E
H
I
L
M
- Maprotiline
- MDPV
- Mephedrone
- Methcathinone
- Methiopropamine
- Methylnaphthidate
- Mexedrone
- Milnacipran
- Moclobemide

